We also analyzed that the higher expression level of FBXW8 was in several cancers, containing Bladder Urothelial Carcinoma (BLCA), BRCA, GBM, CHOL, COAD, HNSC, KIRP, LIHC, LUSC, STAD, PRAD and READ. Here, FBXW8 is linked to bladder transitional cell carcinoma.